ZBTB16
Summary: This gene is a member of the Krueppel C2H2-type zinc-finger protein family and encodes a zinc finger transcription factor that contains nine Kruppel-type zinc finger domains at the carboxyl terminus. This protein is located in the nucleus, is involved in cell cycle progression, and interacts with a histone deacetylase. Specific instances of aberrant gene rearrangement at this locus have been associated with acute promyelocytic leukemia (APL). Alternate transcriptional splice variants have been characterized. [provided by RefSeq, Jul 2008].
| Name | OMIM ID | Ensembl ID | HGNC ID | PHARMGKB ID | Map Location |
|---|---|---|---|---|---|
| zinc finger and BTB domain containing 16 | MIM:176797 | Ensembl:ENSG00000109906 | HGNC:HGNC:12930 | PA37517 | 11q23.2 |
GO terms in ZBTB16
| Term Type | Evidence Type | GO Term ID | GO Des. |
|---|---|---|---|
| BP | IDA | GO:0000122 | negative regulation of transcription by RNA polymerase II |
| BP | ISS | GO:0001823 | mesonephros development |
| BP | IEA | GO:0006351 | transcription, DNA-templated |
| BP | NAS | GO:0006915 | apoptotic process |
| BP | ISS | GO:0007417 | central nervous system development |
| BP | IEA | GO:0008285 | negative regulation of cell proliferation |
| BP | IEA | GO:0009880 | embryonic pattern specification |
| BP | IEA | GO:0009952 | anterior/posterior pattern specification |
| BP | IEA | GO:0016567 | protein ubiquitination |
| BP | IDA | GO:0030097 | hemopoiesis |
| BP | TAS | GO:0030097 | hemopoiesis |
| BP | TAS | GO:0030099 | myeloid cell differentiation |
| BP | IMP | GO:0032332 | positive regulation of chondrocyte differentiation |
| BP | IEA | GO:0034504 | protein localization to nucleus |
| BP | IEA | GO:0035116 | embryonic hindlimb morphogenesis |
| BP | IEA | GO:0035136 | forelimb morphogenesis |
| BP | IEA | GO:0042733 | embryonic digit morphogenesis |
| BP | IEA | GO:0043065 | positive regulation of apoptotic process |
| BP | TAS | GO:0043687 | post-translational protein modification |
| BP | IMP | GO:0045600 | positive regulation of fat cell differentiation |
| BP | ISS | GO:0045638 | negative regulation of myeloid cell differentiation |
| BP | IDA | GO:0045778 | positive regulation of ossification |
| BP | IBA | GO:0045892 | negative regulation of transcription, DNA-templated |
| BP | IDA | GO:0045892 | negative regulation of transcription, DNA-templated |
| BP | NAS | GO:0045892 | negative regulation of transcription, DNA-templated |
| BP | IBA | GO:0045893 | positive regulation of transcription, DNA-templated |
| BP | IDA | GO:0045893 | positive regulation of transcription, DNA-templated |
| BP | IBA | GO:0045944 | positive regulation of transcription by RNA polymerase II |
| BP | IEA | GO:0048133 | male germ-line stem cell asymmetric division |
| BP | IBA | GO:0048856 | anatomical structure development |
| BP | IEA | GO:0051138 | positive regulation of NK T cell differentiation |
| BP | IDA | GO:0051216 | cartilage development |
| BP | IDA | GO:0061036 | positive regulation of cartilage development |
| CC | IBA | GO:0005634 | nucleus |
| CC | IDA | GO:0005634 | nucleus |
| CC | IBA | GO:0005654 | nucleoplasm |
| CC | TAS | GO:0005829 | cytosol |
| CC | IEA | GO:0005886 | plasma membrane |
| CC | IDA | GO:0016604 | nuclear body |
| CC | IDA | GO:0016605 | PML body |
| CC | IDA | GO:0016607 | nuclear speck |
| CC | IDA | GO:0017053 | transcriptional repressor complex |
| CC | IMP | GO:0032991 | protein-containing complex |
| MF | IDA | GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding |
| MF | ISA | GO:0000981 | RNA polymerase II transcription factor activity, sequence-specific DNA binding |
| MF | IDA | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding |
| MF | IDA | GO:0003677 | DNA binding |
| MF | NAS | GO:0003677 | DNA binding |
| MF | IBA | GO:0003700 | DNA-binding transcription factor activity |
| MF | IPI | GO:0005515 | protein binding |
| MF | IEA | GO:0008022 | protein C-terminus binding |
| MF | IEA | GO:0019904 | protein domain specific binding |
| MF | IPI | GO:0042802 | identical protein binding |
| MF | IDA | GO:0042803 | protein homodimerization activity |
| MF | IBA | GO:0043565 | sequence-specific DNA binding |
| MF | IEA | GO:0046872 | metal ion binding |
Gene expression in normal tissue: ZBTB16
Gene-model tissue-cancer distribution: Bubble Plot
Gene-drug pathway distribution
Pathways in ZBTB16
| Database | Pathway ID | Pathway Des. |
|---|---|---|
| reactome | R-HSA-1280218 | Adaptive Immune System |
| reactome | R-HSA-168256 | Immune System |
| reactome | R-HSA-392499 | Metabolism of proteins |
| reactome | R-HSA-597592 | Post-translational protein modification |
| reactome | R-HSA-8951664 | Neddylation |
| reactome | R-HSA-983168 | Antigen processing: Ubiquitination & Proteasome degradation |
| reactome | R-HSA-983169 | Class I MHC mediated antigen processing & presentation |
| kegg | hsa05200 | Pathways in cancer - Homo sapiens (human) |
| kegg | hsa05202 | Transcriptional misregulation in cancer - Homo sapiens (human) |
| kegg | hsa05221 | Acute myeloid leukemia - Homo sapiens (human) |
| wikipathways | WP2858 | Ectoderm Differentiation |
| wikipathways | WP3658 | Wnt-beta-catenin Signaling Pathway in Leukemia |
| wikipathways | WP3893 | Development and heterogeneity of the ILC family |
Gene-Drug: Aster Plot
| Drug ID | Drug Name | Model Num. |
|---|---|---|
| iGMDRD269 | Purmorphamine | 2 |
| iGMDRD506 | Fedratinib | 3 |
| iGMDRD872 | BRD7137 | 3 |
| iGMDRD887 | Compound 23 citrate | 3 |
| iGMDRD188 | Piperlongumine | 3 |
| iGMDRD64 | Parbendazole | 2 |
| iGMDRD300 | Tozasertib | 2 |
| iGMDRD5 | Tyrphostin AG 1478 | 2 |
| iGMDRD202 | Curcumin | 3 |
| iGMDRD138 | PX 12 | 2 |
| iGMDRD870 | BRD63610 | 1 |
| iGMDRD187 | BRD9876 | 1 |
| iGMDRD434 | BMS-536924 | 3 |
| iGMDRD289 | Parthenolide | 2 |
| iGMDRD193 | Fqi1 | 2 |
| iGMDRD61 | Kinetin riboside | 1 |
| iGMDRD57 | Chloropentafluorobenzene | 4 |
| iGMDRD446 | LY 2183240 | 2 |
| iGMDRD154 | NSC23766 | 4 |
| iGMDRD945 | ML214 | 2 |
| iGMDRD394 | BX-795 | 1 |
| iGMDRD123 | Isoevodiamine | 3 |
| iGMDRD579 | PF750 | 2 |
| iGMDRD772 | BRD4770 | 2 |
| iGMDRD151 | CHM-1 | 2 |
| iGMDRD84 | Lovastatin acid | 2 |
| iGMDRD126 | Tipifarnib | 2 |
| iGMDRD781 | Sirolimus | 3 |
| iGMDRD424 | Tamatinib | 3 |
| iGMDRD70 | LHRH analogues or antagonist | 1 |
Gene in drug-gene network: Network Plot

Gene-drug targets distribution
Gene Structure: PDB
Models in ZBTB16

